NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 83 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,345,693 | -15.1% | 747,607 | 0.0% | 0.06% | -26.2% |
| Q3 2022 | $1,585,000 | -21.2% | 747,607 | 0.0% | 0.08% | -24.5% |
| Q2 2022 | $2,011,000 | -38.0% | 747,607 | 0.0% | 0.11% | -9.4% |
| Q1 2022 | $3,245,000 | -16.2% | 747,607 | 0.0% | 0.12% | -36.1% |
| Q4 2021 | $3,873,000 | -15.6% | 747,607 | 0.0% | 0.18% | +43.0% |
| Q3 2021 | $4,590,000 | +25.8% | 747,607 | +107.0% | 0.13% | -44.3% |
| Q2 2021 | $3,648,000 | – | 361,144 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrona Venture Group, LLC | 6,020,770 | $47,848,000 | 7.75% |
| AMAZON COM INC | 1,457,055 | $14,716,000 | 3.85% |
| Ally Bridge Group (NY) LLC | 1,500,000 | $15,150,000 | 3.76% |
| Affinity Asset Advisors, LLC | 900,000 | $9,090,000 | 3.25% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $20,200,000 | 1.32% |
| Perceptive Advisors | 17,822,302 | $180,004,000 | 1.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $8,080,000 | 0.55% |
| HILLMAN CO | 200,000 | $2,020,000 | 0.52% |
| RA Capital Management | 2,471,430 | $24,961,000 | 0.40% |
| Nantahala Capital Management | 1,190,810 | $12,027,000 | 0.34% |